Table 1.
Clinical information of control patients and post COVID-19 patients.
| Baseline characteristics of patients |
Control patients (n = 34) |
Recovered COVID-19 patients (n = 46) |
P value |
||||
|---|---|---|---|---|---|---|---|
| Mean | Min–Max | SEM | Mean | Min–Max | SEM | ||
| Age (years) | 33.09 | 23–38 | 0.60 | 33.43 | 21–44 | 1.02 | n.s. |
| Number of oocytes retrieved in patients ≤ 35 years | 11.84 | 8–23 | 0.85 | 13.80 | 0–30 | 2.21 | n.s. |
| Number of oocytes retrieved in patients > 35 years | 11.11 | 6–16 | 0.95 | 6.95 | 0–15 | 0.95 | 0.0187 |
| MII oocytes (n, %) | 9.03 (79.84%) | 6–16 | 0.61 | 11.98 (82.23%) | 0–30 | 1.41 | n.s. |
| Basal serum estradiol (pg/ml) | 33.00 | 19–46 | 7.81 | 42.70 | 25–56 | 3.45 | n.s. |
| Serum estradiol on trigger day (pg/ml) | 2710 | 400–5772 | 576.9 | 1424 | 325–3728 | 1152 | n.s. |
| Basal serum progesterone (ng/ml) | 1.09 | 0.52–1.86 | 0.18 | 1.37 | 0.30–4.38 | 0.58 | n.s. |
| Basal serum prolactin (ng/ml) | 20.37 | 6.20–48 | 3.01 | 15.74 | 1–36.20 | 1.83 | n.s. |
| AMH (ng/ml) | 2.067 | 0.5–4.4 | 0.32 | 2.917 | 0.31–5.7 | 0.48 | n.s |
| Antral follicles count (AFC) | 12.64 | 7–20 | 0.77 | 12.50 | 4–22 | 0.99 | n.s |
| BMI | 23.43 | 18.70–31 | 0.98 | 23.01 | 18–29.36 | 0.55 | n.s |
| Time from COVID-19 infection (months) | – | – | – | 4.5 | 2–9 | 0.37 | – |
Data are expressed as the mean ± standard error of the mean. Student's t-test was used for comparisons between groups. Statistical significance was defined as <0.05.